Europe's vaccine divide: As scientists scramble for answers to AstraZeneca blood clot puzzle, some nations opt for caution
For 18 hours a day, Andreas Greinacher and his team at Germany's Greifswald University Hospital have pored over blood samples from across Germany and Austria. Their mission: Trying to figure out how and why potentially deadly blood clots have appeared in a handful of patients who received AstraZeneca's coronavirus vaccine. Matthias Schrader/AP Potentially deadly blood clots have appeared in a handful of patients who received AstraZeneca's coronavirus vaccine, despite no link being established with the vaccine. No link has been established with the vaccine, widely used in Europe and other co...